Effects of melatonin on proliferation of cancer cell lines

Journal of Pineal Research

Volumn 25, Issue 4, 1998, Pages 211-218

  Papazisis, Konstantinos T ^a   Kouretas, Demetrios ^b   Geromichalos, George D ^a   Sivridis, Efthimios ^c   Tsekreli, Olga K ^a   Dimitriadis, Konstantinos A ^a   Kortsaris, Alexander H ^a  

^a THEAGENIO CANCER HOSPITAL   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Bromodeoxyuridine; Cancer; Cell lines; In vitro; Melatonin; SRB; Sulforhodamine

Indexed keywords

BROMODEOXYCYTIDINE; BUTHIONINE SULFOXIMINE; ESTROGEN RECEPTOR; ETACRYNIC ACID; GLUTATHIONE; MELATONIN; RHODAMINE; TETRAZOLIUM;

ARTICLE; BREAST CANCER; CANCER CELL; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CYTOTOXICITY; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; PINEAL BODY;

BREAST NEOPLASMS; BUTHIONINE SULFOXIMINE; CELL DIVISION; CELL SURVIVAL; COLONIC NEOPLASMS; DNA REPLICATION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHACRYNIC ACID; FEMALE; GLUTATHIONE; HUMANS; MELATONIN; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0032442440     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.1998.tb00390.x     Document Type: Article

References (32)

1. BREZINSKI, A. (1997) Melatonin in humans. N. Engl. J. Med. 336:186-195.
2. BARTSCH, H., C. BARTSCH, W.E. SIMON, B. FLEHMIG, I. EBELS, T.H. LIPPERT (1992) Antitumor activity of the pineal gland: Effect of unidentified substances versus the effect of melatonin. Oncology 49:27-30.
3. BLASK, D.E., S.T. WILSON, F. ZALATAN (1997) Physiological melatonin inhibition of human breast cancer cell growth in vitro: Evidence for a glutathione-mediated pathway. Cancer Res. 47:1909-1914.
4. CHEN, L.D., B.Z. LEAL, R.J. REITER, M. ABE, E. SWEREYNEK, D. MELCHIORRI, M.L. MELTZ, B. POEGGELER (1995) Melatonin's inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione concentrations. Cancer Lett 91:153-159.
5. CHOU, T.-C. (1976) Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J. Theoret. Biol. 39:253-276.
6. CHOU, T.-C., P. TALALAY (1977) A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J. Biol. Chem. 252:6438-6442.
7. CHOU, T.-C., P. TALALAY (1981) Generalized equations for the analysis of inhibitors of Michaelis-Menden and higher order kinetic systems with two or more mutually exclusive and non-exclusive inhibitors. Eur. J. Biochem. 115:207-216.
8. COS, S., D.E. BLASK (1990) Effects of pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system. Cancer Lett. 50:115-119.
9. COS, S., D.E. BLASK, A. LEMUS-WILSON, A.B. HILL (1991) Effects of melatonin on the cell cycle kinetics and "estrogen-rescue" of MCF-7 human breast cancer cells in culture. J. Pineal Res. 10:36-42.
10. COS, S., E.J. SANCHEZ-BARCELO (1994) Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. Cancer Lett 85:105-109.
11. COS, S., E.J. SANCHEZ-BARCELO (1995) Melatonin inhibition of MCF-7 human breast-cancer cells growth: Influence of cell proliferation rate. Cancer Lett 93:207-212.
12. COS, S., F. FERNANDEZ, E.J. SANCHEZ-BARCELO (1996a) Melatonin inhibits DNA synthesis in MCF-7 human breast cancer cells in vitro. Life Sci 58:2447-2453.
13. COS, S., J. RECIO, E.J. SANCHEZ-BARCELO (1996b) Modulation of the cell cycle time of MCF-7 human breast cancer cells by melatonin. Life Sci. 58:811-816.
14. CRESPO, D., C. FERNANDEZ-VIADERO, R. VERDUGA, V. OVEJERO, S. COS (1994) Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J. Pineal Res. 16:215-222.
15. FOGH, J., G. TREMPE (1975) New human tumor cell lines. In: Human Tumor Cells In Vitro. J. Fogh, ed. Plenum Press, New York, pp. 115-141.
16. GEY, G.O., W.D. COFFMAN, M.T KUBICEK (1952) Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264.
17. HILL, S.M., D.E. BLASK (1988) Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121-6126.
18. HILL, SM., L.L. SPRIGGS, M.A. SIMON, H. MURAOKA, D.E. BLASK (1992) The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 64:249-256.
19. KEYDAR, I., L. CHEN, S. KARBY, F.R. WEISS, J. DELAREA, M. RADU, S. CHAITCIK, H.J. BRENNER (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur. J. Cancer 15:659-670.
20. LEMUS-WILSON, A., P.A. KELLY, D.E. BLASK (1995) Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture. Br. J. Cancer 72:1435-1440.
21. LIBURDY, R.P., T.R. SLOMA, R. SOKOLIC, P. YASWEN (1993) ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation. J. Pineal Res. 14:89-97.
22. MAGAUD, J.P., I. SARGENT, D.Y. MASON (1988) Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake. J. Immunol. Methods 106:95-100.
23. MOLLIS, T.M., L.L. SPRIGGS, S.M. HILL (1994) Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol. Endocrinol. 8:1681-1690.
24. PANZER, A., M.L. LOTTERING, P. BIANCHI, D.K. GLENCROSS, J.H. STARK, J.C. SEEGERS (1998) Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells. Cancer Lett. 122:17-23.
25. PAPAZISIS, K.T., G.D. GEROMICHALOS, K.A. DIMITRIADIS, A.H. KORTSARIS (1997) Optimization of the sulforhodamine B colorimetric assay. J. Immunol. Methods 208:151-158.
26. PAULL, K.D., R.H. SHOEMAKER, M.R. BOYD, J.L. PARSONS, P.A. RISBOOD, W.A. BARBERA, M.N. SHARMA, D.C. BAKER, E. HAND, D.A. SCUDIERO, A. MONKS, M.C. ALLEY, M. GROTE (1988) The synthesis of XTT: A new tetrazolium reagent that is bioreducible to a water-soluble formazan. J. Heterocyclic Chem 25:911-914.
27. SCUDIERO, D.A., R.H. SHOEMAKER, K.D. PAULL, A. MONKS, S. TIERNEY, T.H. NOFZIGER, M.J. CURRENS, D. SENIFF, M.R. BOYD (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48:4827-4833.
28. SKEHAN, P., S.J. FRIEDMAN (1984) Non-exponential growth by mammalian cells in culture. Cell Tissue Kinet. 17:335-343.
29. SKEHAN, P., R. STORENG, D. SCUDIERO, A. MONKS, J. MCMAHON, D. VISTICA, J.T. WARREN, H. BOKESCH, S. KENNEY, MR. BOYD (1990) New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82:1107-1112.
30. SKEHAN, P. (1995) Assays of cell growth and cytotoxicity. In: Cell growth and apoptosis: A practical approach. G.P. Studzinski, ed. Oxford Press, New York, pp. 169-191.
31. SOULE, H.D., L. VASQUEZ, A. LONG, S. ALBERT, M. BRENNAN (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1409-1413.
32. WILSON, A.P. (1984) Characterization of a cell line derived from the askites of a patient with papillary serous cystadenocarcinoma of the ovary. J. Natl. Cancer Inst. 72:513-521.